Dr. Melissa Lynn Abrams, MD

Dr. Abrams practices at Foot and Ankle Center at the Burkland Medical Center - Surgery Center in Silver Spring, Maryland.

Dr. Abrams' NPI, 1023284635, was assigned on May 3, 2008. Dr. Abrams holds Illinois license 036-114282.

Dr. Abrams' primary practice is Foot and Ankle Center at the Burkland Medical Center - Surgery Center, at 10313 Georgia Avenue, Suite 201, Silver Spring, MD 20902. The practice phone is (301) 592-0505.

Dr. Abrams' primary practice is Foot and Ankle Center at the Burkland Medical Center - Surgery Center in Silver Spring, Maryland. The medical group on file is U.S. Dermatology Partners Silver Spring. Dmand AI also links Dr. Abrams to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abrams practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Abrams' primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Abrams is board certified in dermatology by the American Board of Dermatology. Dr. Abrams is licensed in Illinois.

CMS data shows 380 Medicare services from Dr. Abrams across 6 procedure codes in 2024, for 92 Medicare patients. Medicare paid $18,177 for them. Every service was in an office.

CMS counts 92 Medicare patients who saw Dr. Abrams in 2024. The largest group is 65 to 74, with 44 patients. 75% of them have high cholesterol, and 55% have high blood pressure. Their average risk score is 0.75, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Abrams' median patient age at 15, with 58% women.

In 2024, Dr. Abrams wrote 137 Medicare Part D claims for 45 patients. 85% of them were for generic drugs. CMS names the drug for 67 of them, across 4 drugs with 11 or more claims each, at $41,950 in total drug cost. In 2023, CMS named 49 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Abrams for performance year 2024, reported as part of a group. Dr. Abrams accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 110 procedures of removal of skin lesions by Dr. Abrams, more than 76% of the clinicians it reports for that procedure.

Removal of skin cancer: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 1,389 general payments to Dr. Abrams from 40 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 83% of the total. Regeneron Pharmaceuticals, Inc. paid the most, $240,251.